Argitalpenak (8) María Ángeles García del Barrio argitalpenak

2024

  1. 2023 MASCC and ESMO guideline update for the prevention of chemotherapy- and radiotherapy-induced nausea and vomiting

    ESMO Open, Vol. 9, Núm. 2

  2. 2023 updated MASCC/ESMO consensus recommendations: controlling nausea and vomiting with chemotherapy of low or minimal emetic potential

    Supportive Care in Cancer, Vol. 32, Núm. 1

2022

  1. Trastuzumab and thyroid dysfunction: An association to be aware of

    Journal of Cancer Research and Therapeutics, Vol. 18, Núm. 4, pp. 1183-1185

2020

  1. Successful desensitization to oxaliplatin after a single initial dose of omalizumab in a patient with elevated IgE levels

    Journal of Investigational Allergology and Clinical Immunology

2019

  1. Análisis de fármacos. Toxicología

    Principios de bioquímica clínica y patología molecular (Elsevier España), pp. 237-245

2018

  1. Reality of the emetogenic level of irinotecan

    Supportive Care in Cancer, Vol. 26, Núm. 10, pp. 3441-3446

  2. Reduction in mortality associated with secondary cytomegalovirus prophylaxis after solid organ transplantation

    Transplant Infectious Disease, Vol. 20, Núm. 3

2002

  1. Sellado antibiótico de catéteres intravasculares centrales. Presentación de un caso tipo y de un protocolo de sellado antibiótico

    Revista de medicina, Vol. 46, Núm. 4, pp. 29-32